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Abstract 
 
Purpose:  To discuss complications of simultaneous bilateral percutaneous 
nephrolithotomy (SB-PCNL) when compared to unilateral percutaneous 
nephrolithotomy (U-PCNL) and survey surgeon preference in bilateral stone 
disease management. 
Materials and Methods: 
A database of all participating PCNL patients who received treatment at Indiana 
University Health Methodist Hospital within a 10-year period from 2006 to 2015 
by a single surgeon (JL) was utilized. Perioperative data as well as 
complications, as defined according the Clavien grading system, were recorded.  
A survey of members of the Endourological Society was performed regarding 
surgical management in the setting of bilateral stone disease.  
Results 
A total of 563 patients were identified over the study period with 129 undergoing 
SB-PCNL.  Overall, SB-PCNL patients had a longer procedure (176.9 vs115.6 
min, p<0.0001), were more likely to undergo a secondary procedure (73% vs 44 
p<0.001), and had a longer hospital stay (3.2 vs 2.3 days, p<0.001). Notably, 
there were no differences in number or severity of complications between the two 
groups.   
A total of 153 endourologists completed the survey.  Of these 58 (38%) perform 
bilateral PCNL under anesthesia.  The top reasons for electing to not perform 
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bilateral PCNLs included: duration of bilateral procedures (53%), bilateral renal 
injury (48%), rarely perform bilateral surgery (35%).   
Conclusions 
Although procedure length was longer in the SB-PCNL group there were similar 
rates of complications and severity between U-PCNL and SB-PCNL.  A majority 
of endourologists surveyed do not perform bilateral PCNL but would perform 
bilateral URS with duration of the procedure and concern for bilateral renal injury 
representing the most common reasons.    
 
 
 
Introduction 
 
Since the first PCNL in 1976, percutaneous nephrolithotomy (PCNL) has become 
the standard of care for treatment of large and complex nephrolithiasis. 1 While 
recent reports have demonstrated that PCNL is a safe procedure with acceptable 
post-operative complication rates, there are certain circumstances where there is 
a theoretical increased risk of complications. 2 3 4 Bilateral stone disease presents 
a unique challenge to the treating urologist, in particular when there is significant 
stone burden warranting PCNL.  SB-PCNL was first reported by Colon-Perez in 
1987 and while there is a hypothetical increased risk to simultaneous bilateral 
PCNL (SB-PCNL), multiple investigations have demonstrated its safety and 
efficacy as well as decreased cost in the complex stone patient5 6-9.  However, a 
study from Hungary did report an increased risk of complications with SB-PCNL 
compared to unilateral PCNL (U-PCNL).10 
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Although complication rates associated with PCNL in the reported literature are 
low, classification of these complications can be difficult as there are currently 
many surgical technique variations, including radiologist assisted access as well 
as other ancillary procedures, utilization of lithotripsy and scope technology, and 
surgical approaches, which can lead to varied interpretation of what constitutes a 
complication.2 With this in mind, recent publications have aimed to categorize 
complications utilizing the widely accepted modified Clavien classification.11 
Although there have been reports utilizing the modified complication classification 
system comparing SB-PCNL and U-PCNL, these have typically been small 
series.  The lack of robust literature regarding this clinical question led to the 
development of a survey submitted to the Endourological Society email listserv.  
Therefore, we aim to add to the current body of literature with a large institutional 
series and to discuss surgeon preference and rationale regarding bilateral stone 
disease cases. 
 
 
Patients and methods 
Patients 
A prospectively maintained database of all participating PCNL patients 
who received treatment at Indiana University Health Methodist Hospital within a 
10-year period from 2006 to 2015 by a single surgeon (JEL) was utilized for 
analysis. Preoperative data including age, gender, comorbidities, anatomical 
anomalies, and preoperative serum creatinine and hemoglobin levels were 
recorded. Additionally, intraoperative data including stone size, total surgical 
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time, length of stay, and secondary procedures were documented. Finally, 
postoperative data, including serum creatinine and hemoglobin levels at 24 hours 
after surgery, and complications, as defined according the Clavien grading 
system, were recorded.  
 
Technique 
Following the placement of a 5 Fr ureteral and bladder catheters, the 
patient was placed in the prone position. Renal access was obtained using an 
18-gauge diamond tip access needle with the number and location of access 
points decided based on the anatomy of the kidney as well as the complexity of 
the stones.  Renal access was obtained by the urologist using a triangulation 
technique.  After verification of access with urine aspiration, a 0.035-inch 
hydrophilic guidewire was passed through the needle and into the renal collecting 
system. In most situations the guidewire, after being positioned in the ureter, was 
exchanged for an Amplatz super stiff working wire; a second safety wire was also 
placed down the ureter. Finally, balloon dilatation was performed and a 30 Fr 
working sheath was placed into the calyx of interest.12 For bilateral PCNL, a 5 Fr 
ureteral catheter was placed in each of the two ureters at the beginning of the 
procedure. The more complex side was always treated first.  
A combination of rigid and flexible nephroscopy was performed, and 
lithotripsy was carried out using a combination of ultrasonic, pneumatic, and 
holmium laser energy. In most cases of PCNL, a 10 Fr Cope loop catheter was 
left in the renal collecting system and a 5 Fr open-ended catheter was placed 
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antegradely in the ureter. All patients had a blood draw on postoperative day 
(POD) 1 as well as a noncontrast CT scan. All patients with fragments on their 
CT scan underwent a secondary procedure on POD 2. Nephrostomy tube 
removal was attempted on postoperative day one if the CT indicated that the 
renal unit was stone free.  If residual fragments remained after a secondary 
procedure, patients underwent a third procedure to render them stone free. 
Complications within 30 days of the procedure were recorded and 
classified according to the Clavien system of grading complications with the 
categorization recommended by de la Rosette et al.11. All analyses were 
performed using JMP®, Version 12.0. (SAS Institute Inc., Cary, NC, 1989-2007), 
using two-tailed testing with a significance level of 0.05.  
Results 
Preoperative characteristics 
A total of 563 patients were identified over the study period with 129 undergoing 
SB-PCNL.  Clinical baseline characteristics are presented in Table 1.  Mean age 
was 53 (IQR 43-65) and 54 (IQR 44-65) years, p=0.60 with mean BMI of 32.0 
(IQR 25.1-36.6) and 32.1 (IQR 21.3-39), p=0.89 between the U-PCNL and SB-
PCNL groups, respectively.  There was a significant difference in baseline renal 
function between the two groups with mean serum creatinine values of 1.02 
(IQR, 0.79-1.13) and 1.13 (IQR, 0.84-1.25), p=0.02 for U-PCNL and SB-PCNL, 
respectively.  Likewise, the diagnosis of gout (p=0.01) and horseshoe kidney 
(p=0.04) was significantly higher in the SB-PCNL cohort.   
Intra- and postoperative characteristics 
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Overall, patients who underwent SB-PCNL had a longer duration of their 
procedure (176.9 vs115.6, p<0.001), were more likely to undergo a secondary 
procedure (73% vs 44, p<0.001), even when stratified on a renal unit basis (62% 
vs 44, P<0.001).  Thus, the stone free rate after the primary procedure was 27 vs 
56% (p<0.001) in the SB-PCNL and U-PCNL groups, respectively.  The SB-
PCNL group had a longer length of hospitalization (3.2 vs 2.3  days, p<0.001).  
The procedure was terminated early once in each group, due to return of 
purulence with initial puncture in the SB-PCNL and hemorrhage in U-PCNL 
group.  We also identified a conversion from contralateral URS with U-PCNL to 
SB-PCNL in three cases.  Similarly, renal function at 24 hours post-op (1.43 vs 
1.23, p=0.002) and mean hemoglobin (11.2 vs11.7 p=0.007) were both 
significantly decreased in the SB-PCNL group compared to the U-PCNL cohort.  
By 48hrs post-operatively, the renal function was no longer significantly different 
between the two groups (p=0.15).  The proportion of infectious stones was 
similar between the two groups with 10% of both cohorts having infectious 
stones, struvite or carbonate apatite, on analysis. The numbers of complications 
between the two groups were not statistically different with 33% of the SB-PCNL 
cohort and 27%  (p=0.15) of the U-PCNL experiencing a complication (Table 2).  
Likewise, within the complication group there were no differences in severity of 
complications when comparing the U and SB-PCNL groups.  
Survey Results 
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Regarding the survey to the Endourological Society, a total of 153 urologists 
completed the survey. Of these, 58 (38%) perform bilateral PCNL under the 
same anesthesia, 74 (48%) perform bilateral URS but not bilateral PCNL, and 21 
(14%) do not perform bilateral stone procedures under the same anesthetic. 
Those who do not perform bilateral PCNL were willing to offer their patients 
staged PCNLs (88%), unilateral PCNL and contralateral URS (10%) and/or 
unilateral PCNL with observation of the contralateral side (5%). Reasons for 
electing to not perform bilateral PCNLs included: rarely perform bilateral renal 
stone surgery (35%), duration of bilateral procedures (53%), bilateral renal injury 
(48%), bleeding risk (34%), patient discomfort (23%), reimbursement (13%), 
burden of bilateral procedure to operating room staff (11%), and hospital policy 
(6%) (Figure 1).  Urologists who were willing to do unilateral PCNL and 
contralateral URS (n=9) felt their method of treatment was safer (56%), had less 
risk of acute kidney injury (78%), and less blood loss (11%).  Regarding bilateral 
ureteroscopy, 131 urologists (85%) were willing to perform bilateral URS under 
the same anesthesia, while 14% would do staged URS, and 1% would do 
unilateral URS and observe the contralateral side.  
Finally a clinical scenario of a patient with bilateral 2.5cm stones, amenable to 
PCNL was given.  When offered management options, those who perform 
bilateral PCNL, chose bilateral PCNL most often (74%), staged PCNL (12%), 
staged URS (5%), bilateral URS (5%), and unilateral PCNL with contralateral 
URS (4%). Urologists who do not perform bilateral PCNLs elected to perform 
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staged PCNL (83%), staged URS (12%), unilateral PCNL and contralateral URS 
(3%), and bilateral URS (2%).  
 
 
 
 
Discussion 
Over a ten-year period within a single surgeon experience of U and SB-PCNL we 
identified no significant difference in the number of complications or severity of 
complications when using the CROES PCNL study group assigned Clavien 
complication grading system.  The vast majority of our complications were grade 
I or II.  While patients undergoing SB-PCNL did have lower postoperative 
hemoglobins on the first postoperative day, this was not clinically significant as 
there was no difference in transfusion rates between groups.  Furthermore the 
SB-PCNL group had a higher baseline creatinine compared to the U-PCNL so 
the difference in renal function between groups is minimal.  As expected, the 
procedure length and hospital stay was significantly longer and rate of secondary 
procedures was likewise higher in the SB-PCNL cohort.  However, procedure 
length was not twice that of U-PCNL and thus a more efficient procedure for the 
patient.  There was a single Clavien V complication in a patient who was found to 
have widely metastatic colorectal cancer shortly after his procedure and was 
placed on hospice and died within 30 days of his procedure. 
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We also found that the majority of endourologists surveyed do not offer bilateral 
PCNL to their patients as an option for treatment.  The most common concerns 
for not performing bilateral procedures were the duration of the procedure, 
concern for bilateral renal injury and rarely performing the procedure.  While a 
recent survey investigation of endourologists queried other patient management 
topics,13 to our knowledge this is the first survey to the Endourological field 
investigating procedural preference in the setting of bilateral stone disease.  
 
A recent systematic review by Jones et al into the safety and feasibility of SB-
PCNL notes only 11 investigations with a total of 594 patients meeting inclusion 
criteria over a span of 18 years.14  While our patients were significantly older than 
the review, rates of complications were similar. Interestingly, the most common 
complication in this review was fever but the complications were reported utilizing 
the modified Clavien-Dindo classification and likely underestimating the true 
number of complications.  Our investigation would add significantly to the current 
body of literature in both procedure number and by better defining procedure 
specific complications. 
 
Clavien was the first to propose a reporting system to define and classify surgical 
complications to allow for standardized reporting throughout the literature.15 In 
2004, Dindo et al. evaluated the reproducibility of the modified Clavien system 
and found that it correlated well with complexity of surgery and hospital stay.  
The Clavien system serves as the guideline for classification of postoperative 
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morbidity and mortality to this day.16 The creation of a surgical complications 
reporting system has led to the more objective reporting of patient outcomes in 
the literature.  However, the Clavien system is not specialty specific and thus can 
lead to inconsistent reporting of the severity of postoperative complications.  The 
limitations in reporting of complications in PCNL was noted in a recent review by 
Seitz et al. and the authors recommended a modified Clavien system be 
established.2 Therefore, de la Rossette and the Clinical Research Office of the 
Endourology Society (CROES) analyzed the interrater reliability of PCNL 
complications.  After surveying a group of urologists who rated a set of 
complications the authors found low reliability between individuals with regards to 
lower Clavien complications.  In order to reduce this variability in the future, a 
proposed categorization of complications based on the Clavien system was 
constructed based on expert opinion.11 This CROES procedure-specific grading 
system was utilized to define all complications within our investigation. 
 
SB-PCNL was first reported nearly 10 years after initial U-PCNL reports; 
however, 5 17 18 there is limited data comparing the complications associated 
between SB-PCNL and U-PCNL. Looking only at U-PNCL, the CROES PCNL 
Global Study database with 5724 patients reported a complication rate of 20.5% 
using the Clavien complication grading system.19 Desai et al in 2007 
demonstrated a complication rate of 22.2% in 45 patients undergoing SB-
PCNL.20  Holman et al in 2002 compared 150 SB-PCNLs with 300 U-PCNLs.9 
This study found complications rates of 14.3% and 11.3% for patients undergoing 
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SB-PCNL and UPCNL, respectively. Silverstein et al in 2004 compared 19 
patients who underwent staged U-PCNLs to 17 patients who underwent SB-
PCNLs.6 They reported complication rates of 19% and 28% for the staged and 
simultaneous PCNL groups, respectively.  They noted less blood loss in patients 
undergoing SB-PCNL compared to those in a staged approach. However, 
transfusion rates while comparable were noted to be considerable between the 
two groups at 28.6 and 36.8% (p-value=NS) for the SB-PCNL and the 
asynchronous group, respectively.  The transfusion rate of our cohort was not 
significantly different at 2% and 4.7% for U-PCNL and SB-PCNL respectively.  
While overall complication rates were not discussed, blood loss may serve as an 
indicator of the similar morbidity that SB-PCNL has to U-PCNL.   
Although multiple reports have indicated similar morbidity between SB-PCNL and 
U-PCNL, investigators have raised caution in certain circumstances such as 
complex renal anatomy.19 Our investigation did find a difference in complex renal 
anatomy with a significantly higher number of patients undergoing SB-PCNL who 
had a horseshoe kidney.  Nonetheless, there were no statistically significant 
differences within the cohort even with the added anatomic complexity.   
A recent investigation would seem to disagree with the notion of SB-PCNL and 
U-PCNL having similar rates of complications. Kadlec et al., in an institutional 
series of 47 patients over 11 years who underwent bilateral PCNL, noted an 
increase in any complication within the bilateral PCNL group when compared to a 
matched unilateral cohort, with over 50% having a complication compared to 
31% (p=0.01) in the U-PCNL group.10 Renal access was obtained by a 
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radiologist the day prior to the planned procedure.  While the analysis of Kadlec 
et al. utilized the Clavien classification, it did not apply the PCNL specific 
categorization recommended by the CROES group and did not discuss 
prolonged nephrostomy drainage, the most common complication in our cohort.  
While the current investigation is over a similar period of time, we report a 
considerably larger cohort of patients.  Also dissimilar to our series was a rather 
high rate of sepsis in the bilateral cohort (6.4%) of the Kadlec et al study.  In our 
series we noted a sepsis rate of approximately 1% in the entire cohort which may 
in turn be due to our perioperative antibiotic protocol.  This includes a minimum 
of 7 days pre- and 7 days of post-procedural antibiotics. Overall, we note fewer 
complications with no difference in the severity of complications within our series.        
 
While our study represents the largest single series in the literature, it is not 
without limitations.  Our survey results are prone to response bias and may not 
represent the entirety of the Endourological society.  Although our rates of 
complications are similar to that of the reported literature, we are the first to 
utilize the CROES categorization of complications and thus, may have a higher 
rate of Clavien grade 1 and 2 complications.  Our medical center serves as a 
high volume tertiary referral center for stone disease and therefore, the 
generalizability of our patients and outcomes may not reflect that of a smaller 
referral practice.  Finally, although the series represents that of an experienced 
surgeon, it should be noted that as a tertiary teaching hospital residents and 
fellows participated in all aspects of the cases including percutaneous access.   
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Conclusion 
Although U-PCNL and SB-PCNL did have significant differences in certain 
reported metrics including total operative time, likelihood for a secondary 
procedure, and length of hospital stay, rates of complications and severity of 
complications were similar between the two groups.  Thus, SB-PCNL should be 
considered an acceptable treatment alternative for patients with bilateral stone 
burden warranting percutaneous management. We also identified that a majority 
of endourologists surveyed do not perform bilateral PCNL but would perform 
bilateral URS, citing the duration of the procedure and concern for bilateral renal 
injury representing the most common reasons.    
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Figure 1. Graph of Survey results regarding respondents who do not offer B/L 
PCNL 
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Table 1. Preoperative demographics of patients who underwent unilateral or 
simultaneous bilateral percutaneous nephrolithotomy 
n = number of patients 
 
 
Unilateral 
(n=434) 
 
Bilateral (n=129) 
 
P value 
Years of age (mean 
± SD) 
 
53.4 (15.7) 
 
54.3 (15.3) 0.60 
Male gender (%) 45 49 0.42 
BMI (mean ± SD) 32.0 32.1 0.89 
Pre-operative serum 
Creatinine                
(mg/dl, mean ± SD) 
1.02 (0.4) 1.13 (0.5) 0.02 
Pre-operative Hb 
(g/dl, mean ± SD) 
13.7 (1.69) 13.8 (1.79) 0.69 
UTI (%) 48% 52% 0.37 
Hypertension (%) 47% 45% 0.61 
Diabetes (%) 23% 24% 0.81 
Gout (%) 3% 9% 0.01 
Hyperparathyroidism 
(%) 
4% 4% 1.0 
Horseshoe Kidney 
(%) 
2% 6% 0.04 
Staghorn Calculus 
(%) 
45% 40% 0.31 
Calyceal 
diverticulum (%) 
5% 2% 0.09 
Left Stone Burden 
>2cm (%) 
82% 79% 0.50 
Right Stone Burden 
>2cm (%) 
77% 70% 0.24 
Urinary Diversion 
(%) 
2% 2% 1.0 
Paresis  (%) 3% 6% 0.11 
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Table 2. Postoperative characteristics and complications of patients who 
underwent unilateral or bilateral percutaneous nephrolithotomy 
 
 
 
Unilateral 
(n=434) 
 
 
Bilateral (n=129) 
 
P value 
Creatinine, 24hrs post-operative 
(mg/dl, mean ± SD) 
1.23 (0.67) 1.43 (0.62) 0.002 
Creatinine, 48hrs post-operative 
( mg/dl, mean ± SD) 
1.37  (0.89) 1.62 (0.90) 0.15 
Hb@24hrs (g/dl, mean ± SD) 11.7 (1.74) 11.2 (1.76) 0.007 
Transfusion (%) 2.0% 4.7% 0.11 
Length of stay (days; mean, 
range) 2.3 (1-23) 3.2 (1-21) <0.001 
Total surgery time (min) (SD) 115.6 (42.9) 176.9 (54.1) <0.0001 
Secondary procedures (%) 44 73 <0.0001 
Renal units undergoing 
secondary (%) 44 62 <0.0001 
Complications    
Clavien % (n) (overall)  27  (116) 33 (43) 0.15 
 Clavien I 17.8 (77) 19.4 (25) 0.36 
 Clavien II 3.5 (15) 7.8 (10) 0.14 
 Clavien IIIa 0.9 (4) 3.1 (4) 0.83 
 Clavien IIIb 2.5 (11) 0.8 (1) 
  Clavien IVa 1.2 (5) 0.8 (1) 
Clavien IVb 0.7 (3) 1.6 (2) 
Clavien V 0.2 (1) 0 
Most frequent Clavien I complication: Delayed removal of nephrostomy tube 
Most frequent Clavien II complication: Blood loss requiring blood transfusion 
Most frequent Clavien III complication: Edema/clot retention requiring stent 
placement 
Most frequent Clavien lV complication: Sepsis 
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Table 3.  Detailed list of complications by Clavien classification 
Clavien 
grade 
Complications  (U-PCNL/SB-PCNL) 
Grade I (n*) Delayed removal or displacement of nephrostomy tube (32/9) 
Blood loss anemia without need for transfusion (10/2) 
Elevated postoperative temperature (> 38ºC) managed without 
antibiotics (8/7) 
Subcapsular hematoma and/or perinephric hematoma (6/0) 
Small collecting system perforation (6/0) 
Post-operative pain managed with adjunct opioid analgesics (5/4) 
Urinary retention (4/0) 
Hypotension (3/1) 
Electrolyte derangement managed conservatively (1/0) 
Hydrothorax managed expectantly (1/0) 
Desaturation responding to conservative management (1/0) 
Pneumothorax managed with watchful waiting (0/1) 
Grade II (n*) Bleeding requiring transfusions or receipt of blood product (5/6) 
Fever managed with antibiotics (4/1) 
Deep vein thrombosis (3/0) 
Cardiac arrhythmia (2/0) 
Hyposaturation managed by oxygen therapy (1/1) 
Ileus with conservative management (0/1) 
Grade IIIa 
(n*) 
Embolization for pseudoaneurysm and arteriovenous fistula (2/1) 
Hydro/pneumothorax managed by drain/tube placement (1/1) 
Renal abscess treated with aspiration (0/1) 
UTI without organ failure requiring advanced monitoring (1/1) 
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Grade IIIb 
(n*) 
Stent placement for edema/clot (6/1) 
Bladder clot evacuation (3/0) 
Colonic injury (2/0) 
Grade lVa 
(n*) 
Respiratory failure (3/1) 
Acute Renal Failure requiring ICU management (2/0) 
Grade lVb 
(n*) 
Sepsis and multi-organ failure  (3/2) 
Grade V Death (1/0) 
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